Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03238300 · ClinicalTrials.gov registry record · Phase 2
Neuroscience-Informed Treatment Development for Adolescent Alcohol Use
A Phase 2 study of Alcohol Drinking and Control, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT03238300 is a Phase 2 study of Alcohol Drinking and Control that has completed, run by Medical University of South Carolina. The registered enrollment target is 57 participants, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03238300, a Phase 2 study of Alcohol Drinking and Control, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the effect of N-Acetylcysteine (NAC), an over-the-counter antioxidant supplement, on brains of youth (ages 15-19) using magnetic resonance imaging (MRI).
Conditions Studied
Interventions
- DRUG Placebo Oral Capsule
- DRUG N-Acetylcysteine
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2017-10-16 |
| Est. Completion | 2022-03-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03238300
The ClinicalTrials.gov registry entry for NCT03238300 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (91% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 2 interventions - of which Placebo Oral Capsule is the first listed.
NCT03238300 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT03238300 about?
NCT03238300 is a clinical study titled "Neuroscience-Informed Treatment Development for Adolescent Alcohol Use". This study will examine the effect of N-Acetylcysteine (NAC), an over-the-counter antioxidant supplement, on brains of youth (ages 15-19) using magnetic resonance imaging (MRI).
What is the current status of trial NCT03238300?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2017-10-16. Estimated completion is 2022-03-01.
What conditions does trial NCT03238300 study?
This clinical trial studies the following conditions: Alcohol Drinking, Control.
What interventions are being tested in trial NCT03238300?
The interventions under investigation include: Placebo Oral Capsule (DRUG), N-Acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT03238300?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03238300 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
Ketone Ester Intervention in Alcohol Use Disorder
RECRUITING · Phase 2
-
Effects Ketone Supplement and Alcohol on Brain Metabolism
RECRUITING · Phase 2
-
Effect of Nutritional Ketosis on Alcohol Metabolism
RECRUITING · Phase 2
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Acute Effects of Ketone Supplement on Responses to Alcohol Challenge in Healthy Volunteers
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.